77 | Roy Lipski, CEO, Creo cover art

77 | Roy Lipski, CEO, Creo

77 | Roy Lipski, CEO, Creo

Listen for free

View show details

About this listen

 Biosynthetic compounds — including cannabinoids — present the 'last great domestication' says Roy Lipski, CEO of Creo. His company is at the forefront of bringing lab-produced cannabinoids to market, at scale.  Cosmetics and creams will be among the first products to take advantage of this technology and we can look for these products on store shelves in the not-too-distant future. Tune in to hear how:
  • Microorganisms can produce bio-identical compounds, without the waste that comes with plant-produced cannabinoids.
  • A lab can produce a year's crop worth of cannabinoids in 48 hours.
  • We can now produce 'rare' cannabinoids, at scale.
  • Creo is working with consumer packaged goods providers to integrate cannabinoids into products  we use every day — like skincare products — and we can expect to see them on store shelves starting in 2022.

Hosted on Acast. See acast.com/privacy for more information.

What listeners say about 77 | Roy Lipski, CEO, Creo

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.